Search

Marcin K Bugno

from New Hill, NC
Age ~56

Marcin Bugno Phones & Addresses

  • 350 Red Hill Ln, New Hill, NC 27562
  • Raleigh, NC
  • 1206 Park Glen Pl, Durham, NC 27713 (919) 484-2196
  • 6204 Drew Hill Ln, Chapel Hill, NC 27514 (919) 960-2672
  • Cary, NC
  • Athens, GA
  • Lyndhurst, OH
  • Wade, NC
  • 105 Ranchero Ct, Cary, NC 27513 (919) 484-2196

Work

Company: Kbi biopharma inc. Mar 2009 Address: Durham, NC Position: Associate director cell line development

Education

Degree: Ph.D. School / High School: Jagiellonian University, Krakow, Poland 1992 to 1996 Specialities: Biochemistry

Skills

Biotechnology • Biochemistry • Technology Transfer • Protein Chemistry • Biopharmaceuticals • Gmp • Cell Culture • Lifesciences • Chromatography • Molecular Biology • Pharmaceutical Industry • Validation • Protein Purification • Life Sciences • Cell • Vaccines • Elisa • Purification • Protein Expression • Hplc • Cell Biology • Western Blotting • Clinical Research • Proteomics

Emails

Industries

Biotechnology

Resumes

Resumes

Marcin Bugno Photo 1

Head, Expression Technology

View page
Location:
14800 Charlson Rd, Eden Prairie, MN 55347
Industry:
Biotechnology
Work:
KBI BioPharma Inc. - Durham, NC since Mar 2009
Associate Director Cell Line Development

Attagene Inc. - RTP, NC Jul 2004 - Mar 2009
Senior Scientist and Group Leader

Lineberger Comprehensive Cancer Center, UNC - Chapel Hill, NC Aug 2001 - Jun 2004
Research Fellow

TriPath Oncology - RTP, NC Feb 2003 - Dec 2003
Consultant

Department of Biochemistry and Molecular Biology, UGA - Athens, GA Jul 1998 - Jun 2001
Postdoctoral Fellow
Education:
Jagiellonian University, Krakow, Poland 1992 - 1996
Ph.D., Biochemistry
Jagiellonian University, Krakow, Poland 1987 - 1992
M.Sc., Molecular Biology
University of Wolverhampton, Wolverhampton, England 1990 - 1991
B.Sc., Biological Sciences
Skills:
Biotechnology
Biochemistry
Technology Transfer
Protein Chemistry
Biopharmaceuticals
Gmp
Cell Culture
Lifesciences
Chromatography
Molecular Biology
Pharmaceutical Industry
Validation
Protein Purification
Life Sciences
Cell
Vaccines
Elisa
Purification
Protein Expression
Hplc
Cell Biology
Western Blotting
Clinical Research
Proteomics

Publications

Us Patents

Dipeptidylpeptidases And Methods Of Use

View page
US Patent:
20020164759, Nov 7, 2002
Filed:
Nov 8, 2001
Appl. No.:
10/008355
Inventors:
James Travis - Athens GA, US
Jan Potempa - Athens GA, US
Agnieszka Banbula - Chapel Hill NC, US
Marcin Bugno - Chapel Hill NC, US
Assignee:
The University of Georgia Research Foundation, Inc - Athens GA
International Classification:
C12N009/50
C07H021/04
C12P021/02
C12N001/21
C12N015/74
US Classification:
435/219000, 536/023200, 435/069100, 435/320100, 435/252300
Abstract:
The present invention provides isolated polypeptides, dipeptidylpeptidases, active analogs, active fragments, or active modifications thereof, having amidolytic activity for cleavage of a peptide bond between the second and third amino acids from the N-terminal end of a target polypeptide, wherein the target polypeptide has an aliphatic or an aromatic residue as a substituent on the -carbon atom of the second amino acid from the N-terminal end of the peptide. Isolated nucleic acids encoding dipeptidylpeptidases are also provided, as are methods of reducing growth of a bacterium by inhibiting a dipeptidylpeptidase.
Marcin K Bugno from New Hill, NC, age ~56 Get Report